Tibet Cheezheng Tibetan Medicine Co., Ltd. EBITDA for the year ending December 31, 2024: USD 115.51 M

Tibet Cheezheng Tibetan Medicine Co., Ltd. EBITDA is USD 115.51 M for the year ending December 31, 2024, a 1.86% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Tibet Cheezheng Tibetan Medicine Co., Ltd. EBITDA for the year ending December 31, 2023 was USD 113.40 M, a 8.52% change year over year.
  • Tibet Cheezheng Tibetan Medicine Co., Ltd. EBITDA for the year ending December 31, 2022 was USD 104.50 M, a 7.58% change year over year.
  • Tibet Cheezheng Tibetan Medicine Co., Ltd. EBITDA for the year ending December 31, 2021 was USD 97.14 M, a 24.39% change year over year.
  • Tibet Cheezheng Tibetan Medicine Co., Ltd. EBITDA for the year ending December 31, 2020 was USD 78.09 M, a 22.94% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)